← Leaderboards
Valery G Krasnoperov
Vasgene Therapeutics, Inc
$1,663,132
Attributed
$1,663,132
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $811.3K · FY2012–14$1M$750K$500K$250K$0
'12
'13
'14
Funding mix
By agency
NIH$1,663,132 · 3
By mechanism
R44$1,401,047 · 1
R43$262,085 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Xenograft Procedure”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,763,818
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Peter J Houghton · University Of Texas Hlth Science Center$20,565,889
- Connie Suders · Leidos Biomedical Research, Inc.$19,812,417
- David H Sachs · Columbia University Health Sciences$18,932,200
Research focus
Xenograft ProcedureDrug KineticsTumorVenousLungEmbryonic DevelopmentPre-ClinicalResponseTumor GrowthTumor XenograftNeoplastic CellCancer TypeMalignant NeoplasmsBlood VesselsAdultDoseOrganNormal Tissue MorphologyPancreasMutationCell SurvivalMutantPathway InteractionsLung Adenocarcinoma
Grant awards (4)
Development of sEphB4-HSA as Novel Therapeutic in Cancer$589,768
R44 · FY2014 · CA · contact PI
Development of sEphB4-HSA as Novel Therapeutic in Cancer$811,279
R44 · FY2013 · CA · contact PI
sEphB4-HSA A Pre-Clinical Candidate for Oncology$149,607
R43 · FY2012 · CA · contact PI
EphB4 Receptor Tyrosine Kinase RTK Targeted Humanized Monoclonal Antibody h131$112,478
R43 · FY2012 · CA · contact PI